US pharmaceutical giant Pfizer (NSE: PFIZER) has announced a plan to establish a smart medical innovation center in the Qiantang district of Hangzhou city in China. This initiative aims to bolster the Chinese medical industry’s digital innovation capabilities and contribute to the advancement of healthcare solutions in the region.
Empowering the Digital Innovation Space in China’s Medical Industry
The new entity will serve as a hub for gathering top talents within the industry, focusing on addressing industry pain points, and solving challenges through mobile solutions. By leveraging digital innovation, Pfizer’s center aims to enhance the efficiency and effectiveness of medical services, making a significant impact on patient care and healthcare delivery in China.
Collaboration with Local Government and Industry Talents
Significant collaboration with the local government is planned, which will facilitate the integration of the center’s efforts with regional healthcare initiatives. This partnership will not only support the growth of the local economy but also help attract and retain top industry talents, fostering a dynamic ecosystem for medical innovation in the Qiantang district.-Fineline Info & Tech
